MX9200620A - Composicion farmaceutica y metodo para retardar la degeneracion de celulas nerviosas. - Google Patents
Composicion farmaceutica y metodo para retardar la degeneracion de celulas nerviosas.Info
- Publication number
- MX9200620A MX9200620A MX9200620A MX9200620A MX9200620A MX 9200620 A MX9200620 A MX 9200620A MX 9200620 A MX9200620 A MX 9200620A MX 9200620 A MX9200620 A MX 9200620A MX 9200620 A MX9200620 A MX 9200620A
- Authority
- MX
- Mexico
- Prior art keywords
- degeneration
- delaying
- pharmaceutical composition
- nervous cells
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH47091 | 1991-02-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9200620A true MX9200620A (es) | 1992-08-01 |
Family
ID=4187740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9200620A MX9200620A (es) | 1991-02-15 | 1992-02-13 | Composicion farmaceutica y metodo para retardar la degeneracion de celulas nerviosas. |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0499586B1 (es) |
| JP (1) | JPH0570352A (es) |
| KR (1) | KR920016098A (es) |
| AT (1) | ATE138805T1 (es) |
| AU (1) | AU655227B2 (es) |
| CA (1) | CA2061015A1 (es) |
| DE (1) | DE59206442D1 (es) |
| DK (1) | DK0499586T3 (es) |
| ES (1) | ES2087497T3 (es) |
| GR (1) | GR3020155T3 (es) |
| IE (1) | IE74906B1 (es) |
| IL (1) | IL100889A (es) |
| MX (1) | MX9200620A (es) |
| NO (1) | NO179358C (es) |
| NZ (1) | NZ241608A (es) |
| ZA (1) | ZA921091B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993016696A1 (en) * | 1992-02-21 | 1993-09-02 | Ciba-Geigy Ag | Brofaromine as an agent for treating social phobia |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3856295T2 (de) * | 1987-10-22 | 1999-06-17 | Massachusetts Inst Technology | Behandlung des prämenstruellen oder späten lutealsphase-syndroms |
-
1992
- 1992-02-06 IL IL100889A patent/IL100889A/xx not_active IP Right Cessation
- 1992-02-06 AT AT92810085T patent/ATE138805T1/de not_active IP Right Cessation
- 1992-02-06 DK DK92810085.8T patent/DK0499586T3/da active
- 1992-02-06 EP EP92810085A patent/EP0499586B1/de not_active Expired - Lifetime
- 1992-02-06 DE DE59206442T patent/DE59206442D1/de not_active Expired - Fee Related
- 1992-02-06 ES ES92810085T patent/ES2087497T3/es not_active Expired - Lifetime
- 1992-02-10 AU AU10877/92A patent/AU655227B2/en not_active Ceased
- 1992-02-13 KR KR1019920002074A patent/KR920016098A/ko active IP Right Grant
- 1992-02-13 CA CA002061015A patent/CA2061015A1/en not_active Abandoned
- 1992-02-13 NZ NZ241608A patent/NZ241608A/en unknown
- 1992-02-13 MX MX9200620A patent/MX9200620A/es not_active IP Right Cessation
- 1992-02-14 JP JP4028252A patent/JPH0570352A/ja active Pending
- 1992-02-14 NO NO920591A patent/NO179358C/no unknown
- 1992-02-14 IE IE920486A patent/IE74906B1/en not_active IP Right Cessation
- 1992-02-14 ZA ZA921091A patent/ZA921091B/xx unknown
-
1996
- 1996-06-06 GR GR960401246T patent/GR3020155T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE59206442D1 (de) | 1996-07-11 |
| KR920016098A (ko) | 1992-09-24 |
| NO179358C (no) | 1996-09-25 |
| ES2087497T3 (es) | 1996-07-16 |
| AU1087792A (en) | 1992-08-20 |
| EP0499586B1 (de) | 1996-06-05 |
| IE920486A1 (en) | 1992-08-26 |
| IL100889A (en) | 1997-03-18 |
| CA2061015A1 (en) | 1992-08-16 |
| NO179358B (no) | 1996-06-17 |
| NZ241608A (en) | 1997-06-24 |
| AU655227B2 (en) | 1994-12-08 |
| GR3020155T3 (en) | 1996-09-30 |
| ATE138805T1 (de) | 1996-06-15 |
| NO920591L (no) | 1992-08-17 |
| JPH0570352A (ja) | 1993-03-23 |
| EP0499586A1 (de) | 1992-08-19 |
| NO920591D0 (no) | 1992-02-14 |
| ZA921091B (en) | 1992-09-30 |
| IE74906B1 (en) | 1997-08-13 |
| DK0499586T3 (da) | 1996-06-24 |
| IL100889A0 (en) | 1992-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0574313T3 (da) | 1,4-disubstituerede piperaziner til behandling af sygdomme i centralnervesystemet og neuroendocrine sygdomme | |
| DK0725779T3 (da) | Hidtil ukendte (R)-5-Carbamoyl-8-fluor-3-N,N-disubstitueret-amino-3,4-dihydro-2H-1-benzopyraner | |
| ATE211743T1 (de) | Substituierte 3-aminochinuclidine | |
| AU2118488A (en) | Improvements in or relating to methods of treating damaged skin | |
| NO180632C (no) | 1,3-substituerte cykloalkener og cykloalkaner som sentralnervesystem-midler | |
| BR0015416A (pt) | Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos | |
| AU635326B2 (en) | A method for cultivating cells in microporous beads | |
| DK0556329T3 (da) | Substituerede piperaziner som midler til behandling af centralnervesystemet | |
| CA2107552A1 (en) | Use of deprenyl to maintain, prevent loss, or recover nerve cell function | |
| ATE218535T1 (de) | Aminotetralinderivate, deren zusammensetzungen sowie deren verwendung | |
| MX9200620A (es) | Composicion farmaceutica y metodo para retardar la degeneracion de celulas nerviosas. | |
| IL113411A (en) | Pharmaceutical composition for the treatment or prophylaxis of hyperglycaemias comprising moxonidine as active ingredient and process for the production of such composition | |
| FR2647785B1 (fr) | Nouveaux derives de la pyrrolidone, leur procede de preparation et les compositions pharmaceutiques les renfermant | |
| MX9204905A (es) | Acidos aminometanodifosfonicos n-substituidos y procedimiento para su obtencion | |
| SE8603517D0 (sv) | Heterocyclic compounds and their preparation and pharmaceutical formulation | |
| AU4831279A (en) | New compounds | |
| BR0016168A (pt) | Combinações terapêuticas de (s)-2-(benzilaminometil)-2,3,8,9tetrahidro-7h-1,4-dioxi no[2,3 -e]indol-8-ona e neurolépticos para o tratamento ou prevenção de distúrbios psicóticos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| MM | Annulment or lapse due to non-payment of fees |